Selective serotonin reuptake inhibitor-induced urinary incontinence (Q44077576)

29 November 2017

title

Selective serotonin reuptake inhibitor-induced urinary incontinence (English)

1 reference

29 November 2017

0 references

Movig KL

1 reference

29 November 2017

Leufkens HG

1 reference

29 November 2017

Belitser SV

1 reference

29 November 2017

Lenderink AW

1 reference

29 November 2017

Egberts AC

1 reference

29 November 2017

publication date

1 June 2002

1 reference

Pharmacoepidemiology and Drug Safety

29 November 2017

published in

1 reference

29 November 2017

1 reference

29 November 2017

1 reference

29 November 2017

page(s)

271-279

1 reference

Treatment discontinuation with selective serotonin reuptake inhibitors compared with tricyclic antidepressants: a meta-analysis

29 November 2017

cites work

1 reference

Treatment of overactive bladder: other drug mechanisms

21 January 2018

1 reference

Variation in estimates of urinary incontinence prevalence in the community: effects of differences in definition, population characteristics, and study type

21 January 2018

1 reference

Drug-induced bladder and urinary disorders. Incidence, prevention and management.

21 January 2018

1 reference

Mechanism of action of serotonin selective reuptake inhibitors. Serotonin receptors and pathways mediate therapeutic effects and side effects

21 January 2018

1 reference

Neural 5-HT4 receptors in the human isolated detrusor muscle: effects of indole, benzimidazolone and substituted benzamide agonists and antagonists

21 January 2018

1 reference

Characterization of the 5-HT receptor potentiating neuromuscular cholinergic transmission in strips of human isolated detrusor muscle

21 January 2018

1 reference

Prescription sequence analysis: a new and fast method for assessing certain adverse reactions of prescription drugs in large populations.

21 January 2018

1 reference

Rapid method for estimating the risk of acutely controversial side effects of prescription drugs.

21 January 2018

1 reference

Pharmaco-morbidity linkage: a feasibility study comparing morbidity in two pharmacy based exposure cohorts

21 January 2018

1 reference

Role of dopamine D1 and D2 receptors in the micturition reflex in conscious rats

21 January 2018

1 reference

Pharmacological profile of antidepressants and related compounds at human monoamine transporters

21 January 2018

1 reference

Association between oxybutynin and neuropsychiatric adverse effects not confirmed in daily practice

21 January 2018

1 reference

Serotonergic antidepressants and urinary incontinence

21 January 2018

1 reference

5-HT4 receptor agonists and bladder disorders

21 January 2018

1 reference

Cisapride enhances detrusor contractility and improves micturition in a woman with lazy bladder

21 January 2018

1 reference

Effects of apomorphine and L-dopa on the parkinsonian bladder

21 January 2018

1 reference

Vulvo-vaginal candidiasis associated with acitretin

21 January 2018

1 reference

Urinary incontinence in a community-based cohort: prevalence and healthcare-seeking

21 January 2018

1 reference

Comparative sexual side effects of bupropion, fluoxetine, paroxetine, and sertraline

21 January 2018

1 reference

Polypharmacy and its effect on urinary incontinence in a geriatric population

21 January 2018

1 reference

Self-care behaviors of older women with urinary incontinence

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/PDS.705

1 reference

29 November 2017

1 reference